Literature DB >> 8661952

Heated oyster shell-seaweed calcium (AAA Ca) on osteoporosis.

T Fujita1, T Ohue, Y Fujii, A Miyauchi, Y Takagi.   

Abstract

A randomized, prospective, double-blind test was carried out to compare the effects of heated oyster shell-seaweed calcium (AAA Ca), calcium carbonate, and placebo in 58 elderly, hospitalized women with the mean age of 80 divided into three groups. Group A received 900 mg/day Ca as AAA Ca, Group B 900 mg/day Ca as CaCO3, and Group C placebo besides regular hospital diet containing approximately 600 mg Ca/day for 24 months. From the 25th to the 30th month, all groups were given AAA Ca. Lumbar spine and radial bone mineral density (BMD) were measured at 3-month intervals. Urinary Ca/Cr and serum alkaline phosphatase, intact and midportion serum parathyroid hormone (PTH), and calcitonin were also measured at intervals. From the 6th to the 24th month of the study, the ratio of lumbar spine BMD (L2-L4 by DPX, Lunar) to the basal pretest value was consistently and significantly higher in Group A than Group C but not higher in Group B than in Group C. PTH, measured 12 months after the beginning of the study, was lower in Group A than in Group C, but no significant difference was found between Groups B and C. At 3 months after the placebo was switched to AAA Ca in Group C, serum PTH was significantly decreased from the level during placebo supplement. Morning urine Ca/Cr decreased in Groups A after 18 months and in B after 12 months, but not in C. Serum alkaline phosphatase decreased in Group A significantly compared with Group C, but not in Group B. AAA Ca appears to be effective for increasing BMD in elderly subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661952     DOI: 10.1007/bf02508640

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  15 in total

1.  Calcium supplementation and bone loss in middle-aged women.

Authors:  E L Smith; C Gilligan; P E Smith; C T Sempos
Journal:  Am J Clin Nutr       Date:  1989-10       Impact factor: 7.045

2.  Intestinal absorption of oyster shell electrolysate.

Authors:  T Fujita; M Fukase; M Nakada; M Koishi
Journal:  Bone Miner       Date:  1988-09

3.  Long-term effect of calcium supplementation on bone loss in perimenopausal women.

Authors:  P J Elders; P Lips; J C Netelenbos; F C van Ginkel; E Khoe; W J van der Vijgh; P F van der Stelt
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

4.  Calcium intake and bone mass: a quantitative review of the evidence.

Authors:  R G Cumming
Journal:  Calcif Tissue Int       Date:  1990-10       Impact factor: 4.333

5.  Calcium supplementation and postmenopausal bone loss.

Authors:  L Nilas; C Christiansen; P Rødbro
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

6.  Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy.

Authors:  R L Prince; M Smith; I M Dick; R I Price; P G Webb; N K Henderson; M M Harris
Journal:  N Engl J Med       Date:  1991-10-24       Impact factor: 91.245

7.  Intestinal absorption of calcium in rats given diets containing casein or amino acid mixture: the role of casein phosphopeptides.

Authors:  Y S Lee; T Noguchi; H Naito
Journal:  Br J Nutr       Date:  1983-01       Impact factor: 3.718

8.  Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.

Authors:  B Riis; K Thomsen; C Christiansen
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

9.  Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss.

Authors:  J F Aloia; A Vaswani; J K Yeh; P L Ross; E Flaster; F A Dilmanian
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391

10.  Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age.

Authors:  P J Elders; J C Netelenbos; P Lips; F C van Ginkel; E Khoe; O R Leeuwenkamp; W H Hackeng; P F van der Stelt
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

View more
  7 in total

1.  Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.

Authors:  J Wu; L Xu; Y Lv; L Dong; Q Zheng; L Li
Journal:  Osteoporos Int       Date:  2017-03-23       Impact factor: 4.507

2.  Postural stabilizing effect of alfacalcidol and active absorbable algal calcium (AAA Ca) compared with calcium carbonate assessed by computerized posturography.

Authors:  Takuo Fujita; Shoji Nakamura; Mutsumi Ohue; Yoshio Fujii; Akimitsu Miyauchi; Yasuyuki Takagi; Hirofumi Tsugeno
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

Review 3.  Osteoporosis: past, present and future.

Authors:  T Fujita
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Fractional absorption of active absorbable algal calcium (AAACa) and calcium carbonate measured by a dual stable-isotope method.

Authors:  Kazuhiro Uenishi; Takuo Fujita; Hiromi Ishida; Yoshio Fujii; Mutsumi Ohue; Hiroshi Kaji; Midori Hirai; Mikio Kakumoto; Steven A Abrams
Journal:  Nutrients       Date:  2010-07-12       Impact factor: 5.717

5.  Effect of kidney-reinforcing and marrow-beneficial traditional Chinese medicine-intervened serum on the proliferation and osteogenic differentiation of bone marrow stromal cells.

Authors:  DA-An Zhou; Yue-Ning Deng; Lei Liu; Jian-Jun Li
Journal:  Exp Ther Med       Date:  2014-11-11       Impact factor: 2.447

Review 6.  Calcium intake and bone mineral density: systematic review and meta-analysis.

Authors:  Vicky Tai; William Leung; Andrew Grey; Ian R Reid; Mark J Bolland
Journal:  BMJ       Date:  2015-09-29

Review 7.  Research progress on applications of calcium derived from marine organisms.

Authors:  Yangli Xu; Jian Ye; Deqing Zhou; Laijin Su
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.